Inovio Pharmaceuticals (INO) Leases (2019 - 2025)
Historic Leases for Inovio Pharmaceuticals (INO) over the last 7 years, with Q3 2025 value amounting to $7.0 million.
- Inovio Pharmaceuticals' Leases fell 1789.33% to $7.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.0 million, marking a year-over-year decrease of 1789.33%. This contributed to the annual value of $8.1 million for FY2024, which is 1451.68% down from last year.
- Inovio Pharmaceuticals' Leases amounted to $7.0 million in Q3 2025, which was down 1789.33% from $7.4 million recorded in Q2 2025.
- In the past 5 years, Inovio Pharmaceuticals' Leases ranged from a high of $12.5 million in Q1 2021 and a low of $7.0 million during Q3 2025
- In the last 5 years, Inovio Pharmaceuticals' Leases had a median value of $9.5 million in 2023 and averaged $9.8 million.
- Its Leases has fluctuated over the past 5 years, first crashed by 686.39% in 2024, then tumbled by 1789.33% in 2025.
- Inovio Pharmaceuticals' Leases (Quarter) stood at $11.6 million in 2021, then dropped by 11.61% to $10.2 million in 2022, then decreased by 7.2% to $9.5 million in 2023, then decreased by 14.52% to $8.1 million in 2024, then decreased by 14.26% to $7.0 million in 2025.
- Its Leases was $7.0 million in Q3 2025, compared to $7.4 million in Q2 2025 and $7.7 million in Q1 2025.